Business Description
China Regenerative Medicine International Ltd
ISIN : KYG2129W1042
Total Employee Number:
30Compare
Compare
Traded in other countries / regions
08158.Hong KongCNRMF.USA IPO Date
2001-07-18Description
China Regenerative Medicine International Ltd is an investment holding company. The company is engaged in the provision of healthcare products and services. It is engaged in research and development, production and sales of tissue engineering and regenerative medicine products. The business scope of company includes tissue engineering, cosmetics, cell storage, preparation and therapy, hospitals administration and other business division. The segments of the company are Aesthetic medical and beauty services and Medical services. The majority of the company's revenue is derived from its Aesthetic medical and beauty services segment that provides medical beauty products and services. Geographically, the Hong Kong accounts for the majority of the revenue and also has a presence in PRC.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 0.96 | |||||
Debt-to-EBITDA | 3.13 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | -22.06 | |||||
Beneish M-Score | -0.51 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.5 | |||||
3-Year EBITDA Growth Rate | 19 | |||||
3-Year EPS without NRI Growth Rate | 36.2 | |||||
3-Year Book Growth Rate | -21.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.84 | |||||
9-Day RSI | 40.15 | |||||
14-Day RSI | 39.17 | |||||
3-1 Month Momentum % | -21.13 | |||||
6-1 Month Momentum % | -27.27 | |||||
12-1 Month Momentum % | -70.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.14 | |||||
Quick Ratio | 1.12 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 10.35 | |||||
Days Sales Outstanding | 11.24 | |||||
Days Payable | 34.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.2 | |||||
Shareholder Yield % | -14.98 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.17 | |||||
Operating Margin % | -2.21 | |||||
Net Margin % | 38.2 | |||||
EBITDA Margin % | 22.75 | |||||
FCF Margin % | 5.68 | |||||
OCF Margin % | 5.68 | |||||
ROE % | 76.65 | |||||
ROA % | 17.89 | |||||
ROIC % | -1.29 | |||||
3-Year ROIIC % | 7.28 | |||||
ROC (Joel Greenblatt) % | 85.08 | |||||
ROCE % | 18.36 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 2.58 | |||||
PE Ratio without NRI | 2.58 | |||||
Price-to-Owner-Earnings | 2.25 | |||||
PS Ratio | 0.97 | |||||
PB Ratio | 1.29 | |||||
Price-to-Tangible-Book | 1.29 | |||||
Price-to-Free-Cash-Flow | 17.84 | |||||
Price-to-Operating-Cash-Flow | 17.84 | |||||
EV-to-EBIT | 6.94 | |||||
EV-to-EBITDA | 6.94 | |||||
EV-to-Revenue | 1.58 | |||||
EV-to-FCF | 27.77 | |||||
Price-to-GF-Value | 0.37 | |||||
Price-to-Median-PS-Value | 0.26 | |||||
Price-to-Graham-Number | 0.39 | |||||
Earnings Yield (Greenblatt) % | 14.41 | |||||
FCF Yield % | 5.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
China Regenerative Medicine International Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 72.055 | ||
| EPS (TTM) (HK$) | 0.09 | ||
| Beta | -0.4436 | ||
| 3-Year Sharpe Ratio | 0.08 | ||
| 3-Year Sortino Ratio | 0.24 | ||
| Volatility % | 54.53 | ||
| 14-Day RSI | 39.17 | ||
| 14-Day ATR (HK$) | 0.013853 | ||
| 20-Day SMA (HK$) | 0.24795 | ||
| 12-1 Month Momentum % | -70.83 | ||
| 52-Week Range (HK$) | 0.21 - 0.98 | ||
| Shares Outstanding (Mil) | 304.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
China Regenerative Medicine International Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
China Regenerative Medicine International Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2023-09-06 | 0.90 (+5.88%) | ||
| 0.05:1 Stock Split | 2019-05-16 | 5.40 (+3.85%) | ||
| 4:1 Stock Split | 2007-08-29 | 62.00 (-5.34%) |
Show
Entries
China Regenerative Medicine International Ltd Frequently Asked Questions
What is China Regenerative Medicine International Ltd(HKSE:08158)'s stock price today?
The current price of HKSE:08158 is HK$0.23. The 52 week high of HKSE:08158 is HK$0.98 and 52 week low is HK$0.21.
When is next earnings date of China Regenerative Medicine International Ltd(HKSE:08158)?
The next earnings date of China Regenerative Medicine International Ltd(HKSE:08158) is .
Does China Regenerative Medicine International Ltd(HKSE:08158) pay dividends? If so, how much?
China Regenerative Medicine International Ltd(HKSE:08158) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on China Regenerative Medicine International Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers